Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,642
datasets available to search
ShareScore release 0.9.0
Dataset results
2,642 results for “blindness”
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
ClinicalTrials.gov study NCT02616601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)
ClinicalTrials.gov study NCT00600119. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
ClinicalTrials.gov study NCT00645944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy
ClinicalTrials.gov study NCT01286402. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Randomized Double Blind Clinical Trial of Polyhexamethylene Biguanide Impregnated Foam Dressing
ClinicalTrials.gov study NCT00618787. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.
ClinicalTrials.gov study NCT00668837. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependen
ClinicalTrials.gov study NCT02364947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Mo
ClinicalTrials.gov study NCT01838694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial
ClinicalTrials.gov study NCT04588285. IPD Sharing: NO. Countries: 1. Publications: 0.
A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03969719. IPD Sharing: YES. Countries: 2. Publications: 0.
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
ClinicalTrials.gov study NCT00606281. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Deep-brain Stimulation in Obsessive-compulsive Disorder: Randomized, Double-blinded Clinical Trial
ClinicalTrials.gov study NCT03217123. IPD Sharing: YES. Countries: 0. Publications: 4.
Randomized, Blinded, Controlled Clinical Trial of Surgically Facilitated Orthodontic Treatment
ClinicalTrials.gov study NCT01866345. IPD Sharing: Not stated. Countries: 0. Publications: 2.
TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on t
ClinicalTrials.gov study NCT00650832. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
ClinicalTrials.gov study NCT07124208. IPD Sharing: YES. Countries: 1. Publications: 0.
A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
ClinicalTrials.gov study NCT00002249. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
ClinicalTrials.gov study NCT06664619. IPD Sharing: YES. Countries: 11. Publications: 0.
A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets
ClinicalTrials.gov study NCT02063854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
ClinicalTrials.gov study NCT06011577. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT03943550. IPD Sharing: YES. Countries: 5. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.